Abstract
An increasing amount of evidence suggests that the family of nuclear factor kappaB (NF-kappaB) transcription factors plays an important role in synaptic plasticity and long-term memory formation. The present study investigated the regulation of NF-kappaB family members p50, p65/RelA, and c-Rel in the hippocampus in response to metabotropic glutamate receptor (mGluR) signaling. Activation of group I metabotropic glutamate receptors (GpI-mGluRs) with the agonist (S)-3,5-dihydroxyphenylglycine (DHPG) resulted in a time-dependent increase in DNA binding activity of p50, p65, and c-Rel in area CA1 of the hippocampus. An antagonist of mGluR5, 2-Methyl-6-(phenylethynyl)pyridine, inhibited the DHPG-induced activation of NF-kappaB, whereas an antagonist of mGluR1, (S)-(+)-alpha-amino-4-carboxy-2-methylbenzeneacetic acid, did not. Using a series of inhibitors, we investigated the signaling pathways necessary for DHPG-induced activation of NF-kappaB and found that they included the phosphatidyl inositol 3-kinase, protein kinase C, mitogen-activated protein kinase kinase, and p38-mitogen-activated protein kinase pathways. To determine the functional significance of mGluR-induced regulation of NF-kappaB, we measured long-term depression (LTD) of Schaffer-collateral synapses in the hippocampus of c-Rel knock-out mice. Early phase LTD was normal in c-rel(-/-) mice. However, late-phase LTD (>90 min) was impaired in c-rel(-/-) mice. The observations of this deficit in hippocampal synaptic plasticity prompted us to further investigate long-term memory formation in c-rel(-/-) mice. c-rel(-/-) mice exhibited impaired performance in a long-term passive avoidance task, providing additional evidence for c-Rel in long-term memory formation. These results demonstrate that the NF-kappaB transcription factor family is regulated by GpI-mGluRs in the hippocampus and that the c-Rel transcription factor is necessary for long-term maintenance of LTD and formation of long-term memory.
Publication types
-
Comparative Study
-
Research Support, N.I.H., Extramural
MeSH terms
-
Animals
-
Animals, Newborn
-
Avoidance Learning / physiology
-
Behavior, Animal
-
Blotting, Western / methods
-
Dose-Response Relationship, Radiation
-
Electric Stimulation / methods
-
Enzyme Activation / drug effects
-
Enzyme Inhibitors / pharmacology
-
Enzyme-Linked Immunosorbent Assay / methods
-
Excitatory Postsynaptic Potentials / drug effects
-
Excitatory Postsynaptic Potentials / physiology
-
Excitatory Postsynaptic Potentials / radiation effects
-
Gene Expression / drug effects
-
Gene Expression / physiology
-
Glycine / analogs & derivatives
-
Glycine / pharmacology
-
Hippocampus / cytology
-
Hippocampus / drug effects
-
Hippocampus / physiology*
-
Hippocampus / radiation effects
-
In Vitro Techniques
-
Long-Term Synaptic Depression / drug effects
-
Long-Term Synaptic Depression / genetics
-
Long-Term Synaptic Depression / radiation effects
-
Methoxyhydroxyphenylglycol / analogs & derivatives
-
Methoxyhydroxyphenylglycol / pharmacology
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
NF-kappa B / metabolism*
-
Patch-Clamp Techniques / methods
-
Phenylacetates / pharmacology
-
Protein Binding / drug effects
-
Protein Binding / physiology
-
Protein Subunits / physiology
-
Proto-Oncogene Proteins c-rel / deficiency
-
Pyridines / pharmacology
-
RNA, Messenger / biosynthesis
-
Receptors, Metabotropic Glutamate / agonists
-
Receptors, Metabotropic Glutamate / antagonists & inhibitors
-
Receptors, Metabotropic Glutamate / classification
-
Receptors, Metabotropic Glutamate / physiology*
-
Reverse Transcriptase Polymerase Chain Reaction / methods
-
Signal Transduction / drug effects
-
Signal Transduction / physiology*
-
Synaptic Transmission / drug effects
-
Synaptic Transmission / physiology
-
Time Factors
Substances
-
2-chloro-5-hydroxyphenylglycine
-
Enzyme Inhibitors
-
NF-kappa B
-
Phenylacetates
-
Protein Subunits
-
Proto-Oncogene Proteins c-rel
-
Pyridines
-
RNA, Messenger
-
Receptors, Metabotropic Glutamate
-
Methoxyhydroxyphenylglycol
-
6-methyl-2-(phenylethynyl)pyridine
-
Glycine
-
3,4-dihydroxyphenylglycol